Abstract:Background Contemporary risk scores for ischemic or bleeding event prediction after drug-eluting stent (DES) implantation are limited to the determination of a single time duration for dual antiplatelet therapy (DAPT) and lack flexibility in providing dynamic risk stratification.Objectives This study sought to develop artificial intelligence (AI) models to dynamically predict the ischemic and bleeding risks at different time intervals for patients with DES implantation for personalized decision support for antiplatelet therapy.Methods We identified 81,594 adult patients who received DES implantation in the United States from the Cerner HealthFacts® dataset. The total prediction window covered 12-30 months after DES implantation. We designed eight prediction scenarios with four prediction intervals (3, 6, 12, and 18 months). Five AI models were developed for the ischemic and bleeding risk stratification. Model performance was assessed using the area under the receiver operating characteristic curve (AUROC).Results Our proposed AI model outperformed the clinical guideline-recommended tool–the DAPT score– for 12m-30m prediction (with AUROC 0.82 vs. 0.79 for ischemia, 0.77 vs 0.72 for bleeding). In the scenarios that are not covered by the DAPT score, our models demonstrated robust performance (AUROC ranges were 0.79–0.80 for ischemia and 0.75–0.76 for bleeding).Conclusions As the first effort dedicated to dynamically forecasting adverse endpoints after DES implantation given DAPT continuation or discontinuation, our AI-empowered approach demonstrates superior capabilities for risk stratification, holding value as a novel clinical tool that can refine the prognostic judgments of clinicians and achieve optimal DAPT management.Condensed abstract We proposed an innovative AI-based dynamic prediction system that forecasts the ischemic and bleeding events after coronary stenting in varying time intervals given DAPT continuation or discontinuation. Our AI model not only demonstrated superiority compared with the clinical guideline-recommended tool–the DAPT score in the 12-30 months prediction, but also achieved robust performance in other scenarios that were not covered by the DAPT score. Our AI-driven approach holds value as a novel clinical tool that can refine the prognostic judgments of clinicians, enable better informed clinical decisions, and facilitate optimal DAPT management in the context of precision cardiovascular medicine.### Competing Interest StatementThe authors have declared no competing interest.### Funding StatementThis study was funded by the American Heart Association under Award No. 19GPSGC35180031### Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board (IRB) at UTHealth has approved the study protocol.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available for licensing at Cerner Corporation* AI : artificial intelligence CABG : coronary artery bypass graft CKD : chronic kidney disease CRUSADE : can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the ACC/AHA guidelines DAPT : dual antiplatelet therapy PARIS : patterns of non-adherence to antiplatelet regimen in stented patients PCI : percutaneous coronary intervention PRECISE-DAPT : predicting bleeding complication in patients undergoing stent implantation and subsequent dual antiplatelet therapy

Optimizing Platelet Transfusion through a Personalized Deep Learning Risk Assessment System for Demand Management.

Demand Forecasting for Platelet Usage: from Univariate Time Series to Multivariate Models

Demand forecasting for platelet usage: From univariate time series to multivariable models

Personalized Surgical Transfusion Risk Prediction Using Machine Learning to Guide Preoperative Type and Screen Orders

Development, validation, and usability evaluation of machine learning algorithms for predicting personalized red blood cell demand among thoracic surgery patients

From demand forecasting to inventory ordering decisions for red blood cells through integrating machine learning, statistical modeling, and inventory optimization

Machine learning in the prediction of massive transfusion in trauma: a retrospective analysis as a proof-of-concept

Many happy returns: machine learning to support platelet issuing and waste reduction in hospital blood banks

Robust Meta-Model for Predicting the Need for Blood Transfusion in Non-traumatic ICU Patients

Dynamic Prognosis Prediction for Patients on DAPT after Drug‐Eluting Stent Implantation: Model Development and Validation

Machine learning derived model for the prediction of bleeding in dual antiplatelet therapy patients

AI-aided Dynamic Prediction of Bleeding and Ischemic Risk after Coronary Stenting and Subsequent DAPT

How do I/we forecast tomorrow's transfusion? A focus on recipients' profiles

Predicting the Need for Blood Transfusion in Intensive Care Units with Reinforcement Learning

Construction and Validation of an Assistant Decision-Making Model for Platelet Transfusion Refractoriness in Patients with Acute Myeloid Leukemia

Personalized prediction of intradialytic hypotension in clinical practice: Development and evaluation of a novel AI dashboard incorporating risk factors from previous and current dialysis sessions

Machine learning for real-time prediction of complications in critical care: a retrospective study

Development of the Platelet Efficacy Score (PEscore) to predict the efficacy of platelet transfusion in oncohematologic patients

Prediction of red blood cell transfusion after orthopedic surgery using an interpretable machine learning framework

Development of blood demand prediction model using artificial intelligence based on national public big data

Non-invasive prediction of massive transfusion during surgery using intraoperative hemodynamic monitoring data